Matthieu Peigné is a Regulatory Program Director with over a decade of experience in the pharmaceutical industry, notably at Roche and Genentech. Currently, Matthieu leads global regulatory efforts for the development and registration of diverse molecules, driving cross-functional teams to bring innovative medicines to market. In previous positions, Matthieu was accountable for initial marketing applications and provided strategic regulatory input across various therapeutic areas. Matthieu holds a PharmD and a Master's degree in International Drug Development and Registration, alongside ongoing education in Organizational Leadership.
Location
Basel, Switzerland